台灣前列腺癌病人接受根除性前列腺全切除手術的餘命估算-2020年趨勢

盧致誠^1.2 范文宙¹ 鄭哲舟¹

奇美醫療財團法人柳營奇美醫院 外科部 泌尿外科

TREND OF LIFE EXPECTANCY OF PATIENTS FOR RADICAL PROSTATECTOMY OF PROSTATE CANCER IN TAIWAN—2020 UPDATE

Chih-Cheng Lu^1.2, Wen-Chou Fan¹, Tse-Chou Cheng¹

¹Division of Urology, Department of Surgery, Chi Mei Medical Center, Liouying, Tainan

²Department of Information Management, National Chung Cheng University, Chiayi

Purpose:

This study is to review the trend of life expectancy of male population in Taiwan region for the reference in clinical practice.

Materials and Methods:

Up to March 2021, life expectancy reports by the service of the Department of Statistics, Ministry of the Interior (MOI) of Taiwan were reviewed. The printed practice guidelines for prostate cancer by Taiwan Cooperation Oncology Group TCOG and National Comprehensive Cancer Network (NCCN) were reviewed. Investigate the trend of life expectancy of the male population in Taiwan region which includes Taipei city, Kaohsiung city but no Fukien special areas. Life expectancy of the patients receiving radical prostatectomy in localized prostate cancer is 10 years or more, based on TCOG and NCCN.

Results:

From 1991 to 2016 life table by Taiwanese MOI were available. Average 5-year survival rate of prostate cancer is around 77% mentioned by TCOG. Radical prostatectomy is considered when the patients with a life expectancy of 10 years or more and no serious co-morbid conditions that would contraindicate an elective surgery by NCCN in 2018. From 1991 to 2012, the male life expectancy at birth in Taiwan was from 71.8 up to 76.4 years. The report of life expectancy more than 10 years from MOI showed at the age of 71 years in 1991, 72 years from 1992 to 1995, 74 years in 1996, 75 years from 1997 to 1999, 76 years from 2001 to 2005, 77 years in 2006 to 2007. In 2012, the male life expectancy at the age of 77 and 78 years were 10.13 and 9.62 years, respectively. In 2013, the male life expectancy at the age of 77 and 78 years were 10.41 and 9.88 years, In 2016, the male life expectancy at the age of 76, 77 and 78 years were10.27, 9.72 and 9.18 years, In 2019, the male life expectancy at the age of 76, 77, 78 and 79 years were11.17, 10.58, 10.00 and 9.44 years.  

Conclusion:

In this timely updating study, 79 years of age is the upper limit for the patients with localized prostate cancer considering to undergo radical prostatectomy based on practice guidelines in Taiwan region. Further research with longer follow-up is needed to clarify the relationship.